After long battle, FDA OK's Teva Plan B One-Step without Rx, age restrictions
This article was originally published in Scrip
Executive Summary
The US FDA on 20 June said it would permit Teva to sell its single-pill emergency contraceptive Plan B One-Step (1.5 mg levonorgestrel tablet) without a prescription or age restrictions – ending a battle that stretched across three administrations, pitting scientists against policymakers.